Pharmaceutical Division
Dapagliflozin
Dapagliflozin is an SGLT2 inhibitor API used in metabolic and glycemic management.
Anti-diabeticCAS 461432-26-8
Quality Assured
SGLT2 inhibitor
N/A
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Dapagliflozin – CAS 461432-26-8
CAS Number
461432-26-8
Category
Anti-diabetic
Therapeutic Class
SGLT2 inhibitor
Description
Dapagliflozin is an SGLT2 inhibitor API used in metabolic and glycemic management.
Applications
- Type 2 diabetes mellitus
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.